Location Basel, Basel-Stadt, Switzerland Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Philipp has a Ph.D. in Microbiology from the University of Basel and did his postdoc at the Institut Pasteur in Paris. Philipp's previous positions were antifungal compound development at Evolva and Polyphor. Philipp joined Allecra Therapeutics GmbH at the beginning of 2017. After successfully supporting the clinical development of EXBLIFEP®
(cefepime-enmetazobactam) for Complicated Urinary Tract Infections in February 2020 at Allecra SAS he joined the startup discovery bio group as CSO. He supports Selmod in all aspects of clinical microbiology.
